Law channel feed – Endpoints News

Law channel feed

Trump administration loses bid to move ahead with HHS firings, reorganization

Yesterday

AstraZeneca agrees to pay $51M to settle ‘pay-for-delay’ class action suit

2 days ago

Supreme Court to keep mulling state PBM dispute as US urges justices to decline case

3 days ago

Eisai, Merck stave off generic competition to blockbuster cancer drug Lenvima

3 days ago

Axsome and Hetero settle patent fight over sleep disorder drug

5 days ago

Sernova chair resigns following insider trading indictment over Novartis-Chinook deal

5 days ago

US warns drugmakers against misrepresenting cost of imported products

Last week

Federal judge extends order blocking RFK Jr. from reorganizing HHS

Last week

House passes Trump tax bill with PBM and orphan drug reforms included

Last week

Teva, Novartis get fresh warnings from FTC over Orange Book patent listings

Last week

Updated: Trump administration reveals 'most favored nation' drug price country targets

Last week

HHS can require approval for drugmakers to apply 340B rebate models, court rules

3 weeks ago

Amarin calls Hikma's drug label arguments 'idiosyncratic,' urges high court to decline case

3 weeks ago

Regeneron scores $400M+ jury win in Amgen cholesterol drug spat

3 weeks ago

CRISPR patent spat revived by federal appeals court ruling

3 weeks ago

HHS focuses on 'transparency' in third-round IRA negotiation guidance

3 weeks ago

Lack of detail in Trump's drug price plan raises more questions than answers

3 weeks ago

PBM overhaul and drug price negotiations make the cut in Republicans' tax bill

3 weeks ago

AstraZeneca loses appeals court fight over IRA drug price negotiations

4 weeks ago

Avadel can pursue label expansion for narcolepsy drug Lumryz after court ruling

4 weeks ago

Compounders just lost their case to put obesity drug tirzepatide back in shortage

4 weeks ago

States sue US over plan for reorganization of federal health agencies

4 weeks ago

Exclusive: SEC expected to drop investigation of Illumina's $8B Grail deal

4 weeks ago

BeiGene scores a win from US Patent Office in spat over Brukinsa

Last month

12 3 4 Next page Last page